The center, with more than 120 faculty members, builds on the multidisciplinary nature of research into the immune system, with links between infection biology, vaccine development, genetics, genomics, malignancy and biomedical engineering. Read the ...
Read More
A newly discovered small molecule could be sprayed into people’s noses to prevent COVID-19 illness prior to exposure and provide early treatment if administered soon after infection, according to a study in mice led ...
Read More
North American white-tailed deer – shown in 2021 surveys of five states to have SARS-CoV-2 infection rates of up to 40% – shed and transmit the virus for up to five days once infected, ...
Read More
A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a ...
Read More
Assistant professors Pamela Chang, Antonio Fernandez-Ruiz, Daniel Halpern-Leistner and Peter McMahon have won 2022 Sloan Research Fellowships from the Alfred P. Sloan Foundation. Read the full story here.
An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury in severe COVID-19 cases, according to a preclinical study from researchers at Weill Cornell Medicine ...
Read More
A specific group of fungi residing in the intestines can protect against intestinal injury and influence social behavior, according to new preclinical research by scientists at Weill Cornell Medicine. Read the full story here.
Eight Center for Immunology members has been awarded Seed Funds from Cornell University’s Office of Academic Integration. The grants will support a wide array of work from research on a Pan-Coronavirus vaccine to a ...
Read More
Cornell researchers have for the first time imaged the entire depth of the lymph nodes in a living mouse using three-photon microscopy, which enabled them to observe the dynamic interactions of immune cells. Read ...
Read More
A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine. Read the full ...
Read More
